Our Standards
Every compound in the Hot Peps catalog is held to documented quality standards covering selection, testing, packaging, storage, and compliance. This page describes our approach at each stage.
Compound Selection Criteria
Every compound in our catalog is selected based on the depth and quality of its published research history. We evaluate the available clinical and preclinical literature, prioritizing compounds with peer-reviewed studies, identified mechanisms of action, and documented safety profiles in research settings.
We do not carry compounds based on social media trends, unsubstantiated claims, or consumer demand alone. A compound must have a meaningful body of published research before it is considered for inclusion. Our current catalog of 9 compounds across 4 series reflects this selective approach.
- Minimum threshold of peer-reviewed publications documenting the compound
- Identified mechanism of action supported by published research
- Established synthesis and purification methodology
- Viable commercial-scale production at research-grade purity levels
Each compound's research documentation is summarized on its individual Research Hub page, including key citations with PubMed references where available.
Purity Standards & Analytical Testing
All compounds in the Hot Peps catalog meet a minimum purity standard of ≥98%, with the majority tested at ≥99%. Purity refers to the proportion of the target peptide sequence relative to all other material present in the sample, including synthesis by-products, truncated sequences, and residual reagents.
High-Performance Liquid Chromatography (HPLC)
The primary method used to assess peptide purity is reversed-phase high-performance liquid chromatography (RP-HPLC). This technique separates the components of a peptide sample based on their hydrophobic interactions with a C18-bonded silica stationary phase, using a gradient of water and acetonitrile as the mobile phase.
The resulting chromatogram displays peaks corresponding to each separated component. Purity is calculated by comparing the area of the target peptide peak to the total area of all detected peaks. A single dominant peak with minimal satellite peaks indicates high purity. Analytical conditions — including column type, gradient program, flow rate, and detection wavelength — are optimized for each compound.
Mass Spectrometry (MS)
Mass spectrometry is used as a complementary verification method to confirm molecular identity. While HPLC quantifies purity, MS measures the mass-to-charge ratio of ionized molecules, providing a precise molecular weight that is compared against the theoretical value calculated from the peptide's amino acid sequence.
Electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI) are the two most common techniques used for peptide molecular weight confirmation. A match between observed and expected molecular weight — typically within ±1 dalton — provides strong confirmation that the correct sequence has been synthesized.
Certificate of Analysis (COA)
Third-party analytical documentation is maintained for every production batch. A Certificate of Analysis typically includes:
- HPLC chromatogram showing the purity profile and peak area percentage
- Mass spectrometry report confirming molecular identity and observed molecular weight
- Appearance description (typically white to off-white lyophilized powder)
- Lot number and production date for batch traceability
- Stated purity percentage based on HPLC analysis
This documentation enables researchers to verify that received material meets the specifications required for their investigations and supports lot-to-lot traceability across multiple experimental series.
Synthesis & Sourcing
Compounds in the Hot Peps catalog are produced through solid-phase peptide synthesis (SPPS), the established methodology for manufacturing research-grade synthetic peptides. SPPS involves the sequential addition of protected amino acids to a growing peptide chain anchored to a solid resin support, followed by cleavage, purification, and lyophilization.
Sourcing partners are evaluated based on their manufacturing capabilities, quality control systems, analytical documentation practices, and ability to consistently produce material at the purity levels required for our catalog. We maintain documentation of sourcing relationships and evaluate batch consistency over time.
Packaging & Storage
All compounds are supplied as lyophilized (freeze-dried) powder in sealed, sterile vials. Lyophilization removes water from the peptide solution under reduced pressure, producing a dry powder that is more chemically stable than a peptide in solution. This format minimizes hydrolysis and other degradation reactions during storage and transport.
Storage Recommendations
- Long-term storage: -20°C (freezer) for maximum stability
- Short-term storage: 2–8°C (refrigerator) for periods up to several months
- Protect from direct light, excessive heat, and moisture
- Minimize freeze-thaw cycles for reconstituted material
- Store sealed vials upright in a dry environment
Shipping & Packaging Design
Orders are packaged to protect vial integrity during transit. Packaging materials are selected to minimize temperature fluctuation and physical damage. Premium packaging design is intended for both safe initial delivery and convenient long-term storage, supporting researchers who maintain ongoing inventory of multiple compounds.
Research Documentation
Every compound in the catalog is accompanied by summarized research documentation drawn from published clinical and preclinical studies. This documentation is organized into several sections:
- Overview: compound origin, classification, and structure
- Published Research: summarized findings from peer-reviewed studies
- Mechanism of Action: proposed biological pathways based on published literature
- Key Citations: referenced publications with PubMed identifiers where available
- Compound Profile: specifications including purity, form, sequence, and storage
Individual compound research pages are available on the Research Hub, and product-specific documentation appears on each compound product page.
Compliance & Responsible Positioning
Hot Peps maintains a strict compliance posture across all product language, imagery, and marketing materials. This commitment shapes every aspect of how compounds are presented on this site and in all communications.
- All products are sold strictly for in vitro research, laboratory use, and scientific investigation only
- No dosing guidance, therapeutic claims, or administration instructions are provided
- Product descriptions use passive, research-appropriate language throughout
- No before/after imagery, testimonials, or user reviews implying therapeutic outcomes
- Research citations reference published, peer-reviewed sources with PubMed identifiers
- The compliance disclaimer appears on every page of this website
This compliance framework is not a legal disclaimer added as an afterthought — it is the foundation of how Hot Peps operates. Our catalog is built for researchers who value documentation, consistency, and a supplier that takes regulatory positioning seriously.
Current Catalog Overview
The Hot Peps catalog currently includes 9 precision research compounds organized across 4 series, plus 4 curated Signature Kits:
All products are sold strictly for in vitro research, laboratory use, and scientific investigation only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. The information on this page describes our quality practices and does not constitute a warranty or guarantee of fitness for any particular research application.